Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
about
The Roles of NDR Protein Kinases in Hippo SignallingRegulation of protein function by reversible methionine oxidation and the role of selenoprotein MsrB1MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cellsThin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations.Transmembrane semaphorins: Multimodal signaling cues in development and cancer.Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells.Transmembrane semaphorins, forward and reverse signaling: have a look both ways.Actin filaments-A target for redox regulationSEMA6A is a prognostic biomarker in glioblastoma.The role of the semaphorins in cancer.Regulated methionine oxidation by monooxygenases.Redox regulation of the actin cytoskeleton and its role in the vascular system.Characterizing F-actin Disassembly Induced by the Semaphorin-Signaling Component MICAL.Inactivation/deficiency of DHODH induces cell cycle arrest and programed cell death in melanoma.The MICALs are a Family of F-actin Dismantling Oxidoreductases Conserved from Drosophila to Humans.Overexpression of MICAL2, a novel tumor-promoting factor, accelerates tumor progression through regulating cell proliferation and EMT.Amplification of F-Actin Disassembly and Cellular Repulsion by Growth Factor Signaling.MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK/cyclin D pathway.Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes
P2860
Q54897757-1722BB2D-814B-431A-9AB7-FD2EA0CCF2CDQ54904919-995E051D-1FD1-4356-BAA0-25713F041EACQ54904922-EF72CE09-015F-4820-A30E-4473418D52D5Q54904934-24A366E4-852E-46BC-9AE8-3C6A94F1F45FQ54904936-8872984F-906E-4867-97A9-0449C8D3232AQ54904966-96FD2187-0472-475D-BC06-D37BD5D874BDQ54904972-EA2AB931-0CE1-49F8-BA4B-3284E325355DQ54904977-B76A3F80-9549-4748-962F-2FB9DBB11D38
P1343
Q26746889-B1627515-ACBD-4569-977E-792ED3ADD2A6Q28084740-58548617-88D6-4AED-81B6-6B3B4D7FC132Q28384471-0D4B5FAD-648C-4A76-BCF3-7DBC10EC1132Q37327493-B1C91358-BD40-4DE3-839B-881FAB54D429Q37509059-817FBD33-1350-4E32-BC98-1FF142746C91Q38700132-CB8DA5F3-CE6D-42D9-98A6-25406E88DDEDQ38705860-8497F77E-806C-42B9-89F6-7C47DD1E794BQ38866879-EEE9D18B-6D2D-44A7-BBFA-507CAAB7B652Q38870570-B47E9FA6-2E58-485F-82E0-DBBE07C7E056Q38929961-E6B626CF-ED0D-4817-BDAF-9741F8904005Q39147645-4A6B9CAF-887B-4B11-AB75-2B80E20E70FCQ39174495-040F02A5-956E-4B25-9FB0-D6CB153C650BQ47118374-8D5B4014-331A-47B8-BB64-53DF31A11817Q49265106-F9426EFA-4CB9-42CD-8044-6EBDE7691A4FQ49988888-6895678E-5056-4AB0-AF01-C48094BDF7C2Q50311627-33F80E34-7C79-4AD3-915B-8E5AF4845BF0Q50901053-E6C221F0-D453-4F71-9ED9-326ADCD5A860Q52663319-B2912696-ACE7-4D3C-A9BF-0A14111A9095Q58107203-EEB5D627-5B13-4F20-8638-4450197ECDEF
P2860
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
@ast
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
@en
type
label
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
@ast
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
@en
prefLabel
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
@ast
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
@en
P2093
P2860
P4510
P50
P356
P1433
P1476
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells
@en
P2093
Carlo Leonetti
Enzo Gallo
Ilaria Bersani
Maria Felice Brizzi
Paola Baldassari
Paolo Visca
Rita Falcioni
Roberta Mortarini
Valentina Perotti
P2860
P304
P356
10.18632/ONCOTARGET.2995
P407
P577
2015-02-01T00:00:00Z